Clearmind Medicine Inc CMND shares are trading lower by 60.1% to $0.57 Tuesday morning after the company announced a $3.5 million public offering priced at $0.78 per share.
The offering is expected to close on April 6, subject to the satisfaction of customary closing conditions.
See Also: What's Going On With C3.Ai Stock Today?
Clearmind Medicine expects to use the net proceeds from the offering, for general corporate purposes, which may include operating expenses, research and development, including clinical and pre-clinical testing of our product candidates, working capital, future acquisitions and general capital expenditures.
According to data from Benzinga Pro, CMND has a 52-week high of $14.10 and a 52-week low of $0.55.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
